{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:02:03Z","timestamp":1782698523909,"version":"3.54.5"},"publisher-location":"Cham","reference-count":102,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319413327","type":"print"},{"value":"9783319413341","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-41334-1_11","type":"book-chapter","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T07:48:39Z","timestamp":1474876119000},"page":"245-265","source":"Crossref","is-referenced-by-count":40,"title":["Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs"],"prefix":"10.1007","author":[{"given":"Ram","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh K.","family":"Katiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,25]]},"reference":[{"key":"11_CR1","volume-title":"Chinese and related North American herbs: Phytopharmacology and therapeutic values","author":"TSC Li","year":"2002","unstructured":"Li TSC (2002) Chinese and related North American herbs: Phytopharmacology and therapeutic values. CRC Press, Boca Raton, FL"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-07-1926","volume":"14","author":"ER Hahm","year":"2008","unstructured":"Hahm ER, Arlotti JA, Marynowski SW, Singh SV (2008) Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 14:1248\u20131257","journal-title":"Clin Cancer Res"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"35501","DOI":"10.1074\/jbc.M302967200","volume":"278","author":"X Bai","year":"2003","unstructured":"Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Muradm E, Dubiel W, Soff G, Arbiser JL (2003) Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278:35501\u201335507","journal-title":"J Biol Chem"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.179.2.753","volume":"179","author":"ME Munroe","year":"2007","unstructured":"Munroe ME, Arbiser JL, Bishop GA (2007) Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 179:753\u2013763","journal-title":"J Immunol"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02976634","volume":"25","author":"MK Pyo","year":"2002","unstructured":"Pyo MK, Lee Y, Yun-Choi HS (2002) Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch Pharm Res 25:325\u2013328","journal-title":"Arch Pharm Res"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jps.2600700833","volume":"70","author":"AM Clark","year":"1981","unstructured":"Clark AM, El-Feraly FS, Li WS (1981) Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J Pharm Sci 70:951\u2013952","journal-title":"J Pharm Sci"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2004.05.047","volume":"496","author":"J Park","year":"2004","unstructured":"Park J, Lee J, Jung E, Park Y, Kim K, Park B, Jung K, Park E, Kim J, Park D (2004) In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium spp. Eur J Pharmacol 496:189\u2013195","journal-title":"Eur J Pharmacol"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/carcin\/bgq186","volume":"11","author":"M Vaid","year":"2010","unstructured":"Vaid M, Sharma SD, Katiyar SK (2010) Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. Carcinogenesis 11:2004\u20132011","journal-title":"Carcinogenesis"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1751-1097.1996.tb03040.x","volume":"63","author":"H Mukhtar","year":"1996","unstructured":"Mukhtar H, Elmets CA (1996) Photocarcinogenesis: mechanisms, models and human health implications. Photochem Photobiol 63:355\u2013447","journal-title":"Photochem Photobiol"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1142\/9781860948046_0033","volume-title":"Oxidative stress, disease and cancer","author":"SK Katiyar","year":"2006","unstructured":"Katiyar SK (2006) Oxidative stress and photocarcinogenesis: strategies for prevention. In: Singh KK (ed) Oxidative stress, disease and cancer. Imperial College Press, London, pp 933\u2013964"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1562\/0031-8655(2000)072<0788:KOULIC>2.0.CO;2","volume":"72","author":"SK Katiyar","year":"2000","unstructured":"Katiyar SK, Matsui MS, Mukhtar H (2000) Kinetics of UV light- induced cyclobutane pyrimidine dimers in human skin in vivo: an immunohistochemical analysis of both epidermis and dermis. Photochem Photobiol 72:788\u2013793","journal-title":"Photochem Photobiol"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/jid.2008.354","volume":"129","author":"SM Meeran","year":"2009","unstructured":"Meeran SM, Akhtar S, Katiyar SK (2009) Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J Invest Dermatol 129:1258\u20131270","journal-title":"J Invest Dermatol"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jlb.56.6.769","volume":"56","author":"JM Rivas","year":"1994","unstructured":"Rivas JM, Ullrich SE (1994) The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J Leukoc Biol 56:769\u2013775","journal-title":"J Leukoc Biol"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1046-2023(02)00201-3","volume":"28","author":"PH Hart","year":"2002","unstructured":"Hart PH, Townley SL, Grimbaldeston MA, Khalil Z, Finlay-Jones JJ (2002) Mast cells, neuropeptides, histamine, and prostaglandins in UV-induced systemic immunosuppression. Methods 28:79\u201389","journal-title":"Methods"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.4049\/jimmunol.137.8.2478","volume":"137","author":"HT Chung","year":"1986","unstructured":"Chung HT, Burnham DK, Robertson B, Roberts LK, Daynes RA (1986) Involvement of prostaglandins in the immune alterations caused by the exposure of mice to ultraviolet radiation. J Immunol 137:2478\u20132484","journal-title":"J Immunol"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1593\/neo.13424","volume":"15","author":"R Prasad","year":"2013","unstructured":"Prasad R, Katiyar SK (2013) Prostaglandin E2 promotes ultraviolet radiation induced immune suppression through DNA hypermethylation. Neoplasia 15:795\u2013804","journal-title":"Neoplasia"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10409239609108723","volume":"31","author":"S Beissert","year":"1996","unstructured":"Beissert S, Granstein RD (1996) UV-induced cutaneous photobiology. Crit Rev Biochem Mol Biol 31:381\u2013404","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1615\/JEnvironPatholToxicolOncol.v21.i2.120","volume":"21","author":"SM Fischer","year":"2002","unstructured":"Fischer SM (2002) Is cyclooxygenase-2 important in skin carcinogenesis? J Environ Pathol Toxicol Oncol 21:183\u2013191","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","volume":"68","author":"PS Karia","year":"2012","unstructured":"Karia PS, Han J, Schmults CD (2012) Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States. J Am Acad Dermatol 68:957\u2013966","journal-title":"J Am Acad Dermatol"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.294.6.681","volume":"294","author":"LJ Christenson","year":"2005","unstructured":"Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, Roenigk RK (2005) Incidence of basal cell and squamous cell carcinomas in a population younger than 40\u00a0years. JAMA 294:681\u2013690","journal-title":"JAMA"},{"key":"11_CR21","first-page":"777","volume":"30","author":"S Chilampalli","year":"2010","unstructured":"Chilampalli S, Zhang X, Fahmy H, Kaushik RS, Zeman D, Hildreth MB, Dwivedi C (2010) Chemopreventive effects of honokiol on UVB-induced skin cancer development. Anticancer Res 30:777\u2013783","journal-title":"Anticancer Res"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2741\/2834","volume":"13","author":"SM Meeran","year":"2008","unstructured":"Meeran SM, Katiyar SK (2008) Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 13:2191\u20132202","journal-title":"Front Biosci"},{"key":"11_CR23","first-page":"211","volume":"11","author":"X Gra\u00f1a","year":"1995","unstructured":"Gra\u00f1a X, Reddy EP (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211\u2013219","journal-title":"Oncogene"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","volume":"13","author":"CJ Sherr","year":"1999","unstructured":"Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501\u20131512","journal-title":"Genes Dev"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/374131a0","volume":"374","author":"DO Morgan","year":"1995","unstructured":"Morgan DO (1995) Principles of CDK regulation. Nature 374:131\u2013134","journal-title":"Nature"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4161\/cc.3.2.658","volume":"3","author":"R Fotedar","year":"2004","unstructured":"Fotedar R, Bendjennat M, Fotedar A (2004) Role of p21WAF1 in the cellular response to UV. Cell Cycle 3:134\u2013137","journal-title":"Cell Cycle"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","volume":"4","author":"J Luo","year":"2003","unstructured":"Luo J, Manning BD, Cantley LC (2003) Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4:257\u2013262","journal-title":"Cancer Cell"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"25558","DOI":"10.1074\/jbc.M101164200","volume":"276","author":"M Nomura","year":"2001","unstructured":"Nomura M, Kaji A, Ma WY, Zhong S, Liu G, Bowden GT, Miyamoto KI, Dong Z (2001) Mitogen- and stress-activated protein kinase 1 mediates activation of Akt by ultraviolet B irradiation. J Biol Chem 276:25558\u201325567","journal-title":"J Biol Chem"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0955-0674(98)80149-X","volume":"10","author":"J Downward","year":"1998","unstructured":"Downward J (1998) Mechanisms and consequences of activation of protein kinase B\/Akt. Curr Opin Cell Biol 10:262\u2013267","journal-title":"Curr Opin Cell Biol"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/bies.950180210","volume":"18","author":"RM Tyrrell","year":"1996","unstructured":"Tyrrell RM (1996) Activation of mammalian gene expression by the UV component of sunlight-from models to reality. BioEssays 18:139\u2013148","journal-title":"BioEssays"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00432-003-0505-z","volume":"130","author":"M Osaki","year":"2004","unstructured":"Osaki M, Kase S, Adachi K, Takeda A, Hashimoto K, Ito H (2004) Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. J Cancer Res Clin Oncol 130:8\u201314","journal-title":"J Cancer Res Clin Oncol"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1038\/sj.onc.1207641","volume":"23","author":"M Saleem","year":"2004","unstructured":"Saleem M, Afaq F, Adhami VM, Mukhtar H (2004) Lupeol modulates NF-kappaB and PI3K\/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 23:5203\u20135214","journal-title":"Oncogene"},{"key":"11_CR33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0955-0674(96)80060-3","volume":"8","author":"CL Carpenter","year":"1996","unstructured":"Carpenter CL, Cantley LC (1996) Phosphoinositide kinases. Curr Opin Cell Biol 8:153\u2013158","journal-title":"Curr Opin Cell Biol"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1242\/jcs.112.18.3147","volume":"18","author":"NA Callejas","year":"1999","unstructured":"Callejas NA, Casado M, Bosca L, Martin-Sanz P (1999) Requirement of nuclear factor kappaB for the constitutive expression of nitric oxide synthase-2 and cyclooxygenase-2 in rat trophoblasts. J Cell Sci 18:3147\u20133155","journal-title":"J Cell Sci"},{"key":"11_CR35","unstructured":"American Cancer Society. Cancer facts and figures. http:\/\/www.cancer.org\/research\/cancerfactsfigures\/ . Accessed July 2014"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1074\/jbc.M109.030643","volume":"285","author":"EM Lewis","year":"2010","unstructured":"Lewis EM, Sergeant S, Ledford B, Stull N, Dinauer MC, McPhail LC (2010) Phosphorylation of p22phox on threonine 147 enhances NADPH oxidase activity by promoting p47phox binding. J Biol Chem 285:2959\u20132967","journal-title":"J Biol Chem"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1189\/jlb.0804442","volume":"78","author":"FR Sheppard","year":"2005","unstructured":"Sheppard FR, Kelher MR, Moore EE, McLaughlin NJ, Banerjee A, Silliman CC (2005) Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol 78:1025\u20131042","journal-title":"J Leukoc Biol"},{"key":"11_CR38","doi-asserted-by":"crossref","unstructured":"Prasad R, Kappes JC, Katiyar SK (2016) Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells. Oncotarget 7:7899\u20137912","DOI":"10.18632\/oncotarget.6860"},{"key":"11_CR39","doi-asserted-by":"crossref","first-page":"45935","DOI":"10.1074\/jbc.M406486200","volume":"279","author":"RK Ambasta","year":"2004","unstructured":"Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP (2004) Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279:45935\u201345941","journal-title":"J Biol Chem"},{"key":"11_CR40","doi-asserted-by":"crossref","first-page":"22152","DOI":"10.1074\/jbc.271.36.22152","volume":"271","author":"H Sumimoto","year":"1996","unstructured":"Sumimoto H, Hata K, Mizuki K, Ito T, Kage Y, Sakaki Y, Fukumaki Y, Nakamura M, Takeshige K (1996) Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase. J Biol Chem 271:22152\u201322158","journal-title":"J Biol Chem"},{"key":"11_CR41","first-page":"659","volume":"75","author":"JC Hoehner","year":"1996","unstructured":"Hoehner JC, Gestblom C, Hedborg F, Sandstedt B, Olsen L, Pahlman S (1996) A developmental model of neuroblastoma: differentiating stroma-poor tumors\u2019 progress along an extra-adrenal chromaffin lineage. Lab Invest 75:659\u2013675","journal-title":"Lab Invest"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcl.2007.10.014","volume":"55","author":"JR Park","year":"2008","unstructured":"Park JR, Eggert A, Caron H (2008) Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 55:97\u2013120","journal-title":"Pediatr Clin North Am"},{"key":"11_CR43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pbc.21713","volume":"51","author":"PE Zage","year":"2008","unstructured":"Zage PE, Kletzel M, Murray K, Marcus R, Castleberry R, Zhang Y, London WB, Kretschmar C, Children\u2019s Oncology Group (2008) Outcomes of the POG 9340\/9341\/9342 trials for children with high-risk neuroblastoma: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer 51:747\u2013753","journal-title":"Pediatr Blood Cancer"},{"key":"11_CR44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/neuonc\/nor217","volume":"14","author":"JW Lin","year":"2012","unstructured":"Lin JW, Chen JT, Hong CY, Lin YL, Wang KT, Yao CJ, Lai GM, Chen RM (2012) Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic Bax-mitochondrion-cytochrome c-caspase protease pathway. Neuro Oncol 14:302\u2013314","journal-title":"Neuro Oncol"},{"key":"11_CR45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2015.08.030","volume":"370","author":"PS Yeh","year":"2016","unstructured":"Yeh PS, Wang W, Chang YA, Lin CJ, Wang JJ, Chen RM (2016) Honokiol induces autophagy of neuroblastoma cells through activating the PI3K\/Akt\/mTOR and endoplasmic reticular stress\/ERK1\/2 signaling pathways and suppressing cell migration. Cancer Lett 370:66\u201377","journal-title":"Cancer Lett"},{"key":"11_CR46","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3892\/or.2015.4091","volume":"34","author":"X Lv","year":"2015","unstructured":"Lv X, Liu F, Shang Y, Chen SZ (2015) Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells. Oncol Rep 34:1289\u20131300","journal-title":"Oncol Rep"},{"key":"11_CR47","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mc.22242","volume":"54","author":"G Kaushik","year":"2014","unstructured":"Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM (2014) Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog 54:1710\u20131721","journal-title":"Mol Carcinog"},{"key":"11_CR48","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/pros.22837","volume":"74","author":"ER Hahm","year":"2014","unstructured":"Hahm ER, Sakao K, Singh SV (2014) Honokiol activates reactive oxygen species mediated cytoprotective autophagy in human prostate cancer cells. Prostate 74:1209\u20131221","journal-title":"Prostate"},{"key":"11_CR49","first-page":"7168","volume":"15","author":"YB Guo","year":"2015","unstructured":"Guo YB, Bao XJ, Xu SB, Zhang XD, Liu HY (2015) Honokiol induces cell cycle arrest and apoptosis via p53 activation in H4 human neuroglioma cells. Int J Clin Exp Med 15:7168\u20137175","journal-title":"Int J Clin Exp Med"},{"key":"11_CR50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"KC Kim","year":"2015","unstructured":"Kim KC, Guan KL (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 125:25\u201332","journal-title":"J Clin Invest"},{"key":"11_CR51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrc1549","volume":"5","author":"KD Hunter","year":"2005","unstructured":"Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5:127\u2013135","journal-title":"Nat Rev Cancer"},{"key":"11_CR52","first-page":"72","volume":"49","author":"J Casiglia","year":"2001","unstructured":"Casiglia J, Woo SB (2001) A comprehensive review of oral cancer. Gen Dent 49:72\u201382","journal-title":"Gen Dent"},{"key":"11_CR53","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X","volume":"78","author":"JR Grandis","year":"1996","unstructured":"Grandis JR, Melhem MF, Barnes EL, Tweardy DJ (1996) Quantitative immunohistochemical analysis of transforming growth factor-\u03b1 and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 78:1284\u20131292","journal-title":"Cancer"},{"key":"11_CR54","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jnci\/90.14.1080","volume":"90","author":"Y He","year":"1998","unstructured":"He Y, Zeng Q, Drenning SD, Melhem MF, Tweardy DJ, Huang L, Grandis JR (1998) Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. J Natl Cancer Inst 90:1080\u20131087","journal-title":"J Natl Cancer Inst"},{"key":"11_CR55","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/90.11.824","volume":"90","author":"JR Grandis","year":"1998","unstructured":"Grandis JR, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ (1998) Levels of TGF-\u03b1 and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90:824\u2013832","journal-title":"J Natl Cancer Inst"},{"key":"11_CR56","doi-asserted-by":"crossref","first-page":"21268","DOI":"10.18632\/oncotarget.4178","volume":"6","author":"T Singh","year":"2015","unstructured":"Singh T, Gupta NA, Xu S, Prasad R, Velu SE, Katiyar SK (2015) Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor. Oncotarget 6:21268\u201321282","journal-title":"Oncotarget"},{"key":"11_CR57","first-page":"815","volume":"2","author":"JA Crowell","year":"2003","unstructured":"Crowell JA, Steele VE, Sigman CC, Fay JR (2003) Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2:815\u2013823","journal-title":"Mol Cancer Ther"},{"key":"11_CR58","first-page":"527","volume":"28","author":"BD Choi","year":"2011","unstructured":"Choi BD, Jeong SJ, Wang G, Park JJ, Lim DS, Kim BH, Cho YI, Kim CS, Jeong MJ (2011) Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells. Int J Mol Med 28:527\u2013534","journal-title":"Int J Mol Med"},{"key":"11_CR59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.biomaterials.2015.02.091","volume":"53","author":"JH Cho","year":"2015","unstructured":"Cho JH, Jeon YJ, Park SM, Shin JC, Lee TH, Jung S, Park H, Ryu J, Chen H, Dong Z, Shim JH, Chae JI (2015) Multifunctional effects of honokiol as an anti-inflammatory and anticancer drug in human oral squamous cancer cells and xenograft. Biomaterials 53:274\u2013284","journal-title":"Biomaterials"},{"key":"11_CR60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2004.11.048","volume":"120","author":"T Higo","year":"2005","unstructured":"Higo T, Hattori M, Nakamura T, Natsume T, Michikawa T, Mikoshiba K (2005) Subtype-specific and ER lumenal environment-dependent regulation of inositol1,4,5-trisphosphate receptor type 1 by ERp44. Cell 120:85\u201398","journal-title":"Cell"},{"key":"11_CR61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/bies.20370","volume":"28","author":"JS Armstrong","year":"2006","unstructured":"Armstrong JS (2006) Mitochondrial membrane permeabilization: the sine qua non for cell death. BioEssays 28:253\u2013260","journal-title":"BioEssays"},{"key":"11_CR62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704\u2013715","journal-title":"Cell"},{"key":"11_CR63","doi-asserted-by":"crossref","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","volume":"3","author":"AP Morel","year":"2008","unstructured":"Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3:e2888","journal-title":"PLoS ONE"},{"key":"11_CR64","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1158\/0008-5472.CAN-08-3343","volume":"69","author":"M Santisteban","year":"2009","unstructured":"Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC, Manjili MH, Radisky DC, Ferrone S, Knutson KL (2009) Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 69:2887\u20132895","journal-title":"Cancer Res"},{"key":"11_CR65","doi-asserted-by":"crossref","first-page":"29947","DOI":"10.18632\/oncotarget.3844","volume":"6","author":"DB Avtanski","year":"2015","unstructured":"Avtanski DB, Nagalingam A, Bonner MY, Arbiser JL, Saxena NK, Sharma D (2015) Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer. Oncotarget 6:29947\u201329962","journal-title":"Oncotarget"},{"key":"11_CR66","first-page":"2085","volume":"8","author":"Z Shen","year":"2002","unstructured":"Shen Z, Wen XF, Lan F, Shen ZZ, Shao ZM (2002) The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin Cancer Res 8:2085\u20132090","journal-title":"Clin Cancer Res"},{"key":"11_CR67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13046-014-0070-0","volume":"33","author":"J Li","year":"2014","unstructured":"Li J, Liu J, Li P, Mao X, Li W, Yang J, Liu P (2014) Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion. J Exp Clin Cancer Res 33:70","journal-title":"J Exp Clin Cancer Res"},{"key":"11_CR68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.lungcan.2010.02.004","volume":"70","author":"BC Roy","year":"2010","unstructured":"Roy BC, Kohno T, Iwakawa R, Moriguchi T, Kiyono T, Morishita K, Sanchez-Cespedes M, Akiyama T, Yokota J (2010) Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Lung Cancer 70:136\u2013145","journal-title":"Lung Cancer"},{"key":"11_CR69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cdd.2009.56","volume":"17","author":"H Hermeking","year":"2010","unstructured":"Hermeking H (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17:193\u2013199","journal-title":"Cell Death Differ"},{"key":"11_CR70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9\u201329","journal-title":"CA Cancer J Clin"},{"key":"11_CR71","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","volume":"5","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G (2014) Systems biology of cisplatin resistance: past, present and future. Cell Death Dis 5:e1257","journal-title":"Cell Death Dis"},{"key":"11_CR72","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","volume":"21","author":"JA Magee","year":"2012","unstructured":"Magee JA, Piskounova E, Morrison SJ (2012) Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21:283\u2013296","journal-title":"Cancer Cell"},{"key":"11_CR73","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrc3368","volume":"12","author":"P Valent","year":"2012","unstructured":"Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G, Huntly B, Herrmann H, Soulier J, Roesch A, Schuurhuis GJ, Wohrer S, Arock M, Zuber J, Cerny-Reiterer S, Johnsen HE, Andreeff M, Eaves C (2012) Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer 12:767\u2013775","journal-title":"Nat Rev Cancer"},{"key":"11_CR74","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Sinha CK, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624\u2013629","journal-title":"Nature"},{"key":"11_CR75","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/cncr.26441","volume":"118","author":"Ishikawa R Huqun","year":"2012","unstructured":"Huqun Ishikawa R, Zhang J, Miyazawa H, Goto Y, Shimizu Y, Hagiwara K, Koyama N (2012) Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer. Cancer 118:1599\u20131606","journal-title":"Cancer"},{"key":"11_CR76","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1158\/1078-0432.CCR-05-1047","volume":"11","author":"JD Raman","year":"2005","unstructured":"Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ (2005) Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res 11:8570\u20138576","journal-title":"Clin Cancer Res"},{"key":"11_CR77","doi-asserted-by":"crossref","first-page":"37335","DOI":"10.18632\/oncotarget.6135","volume":"6","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, Song J, Shen B, Eliaz I, Huang R, Ying H, Guo H, Yan J (2015) Honokiol inhibits bladder tumor growth by suppressing EZH2\/miR-143 axis. Oncotarget 6:37335\u201337348","journal-title":"Oncotarget"},{"key":"11_CR78","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"4","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 4:679\u2013695","journal-title":"Cell"},{"key":"11_CR79","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3892\/ol.2013.1548","volume":"6","author":"KH Chang","year":"2013","unstructured":"Chang KH, Yan MD, Yao CJ, Lin PC, Lai GM (2013) Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells. Oncol Lett 6:1435\u20131438","journal-title":"Oncol Lett"},{"key":"11_CR80","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjsurg.2012.09.001","volume":"204","author":"G Kaushik","year":"2012","unstructured":"Kaushik G, Ramalingam S, Subramaniam D, Rangarajan P, Protti P, Rammamoorthy P, Anant S, Mammen JM (2012) Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells. Am J Surg 204:868\u2013873","journal-title":"Am J Surg"},{"key":"11_CR81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B Craene De","year":"2013","unstructured":"De Craene B, Berx G (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13:97\u2013110","journal-title":"Nat Rev Cancer"},{"key":"11_CR82","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0002-9440(10)64464-1","volume":"161","author":"E Rosivatz","year":"2002","unstructured":"Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, H\u00f6fler H, Becker KF (2002) Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 161:1881\u20131891","journal-title":"Am J Pathol"},{"key":"11_CR83","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.3390\/ijms13056399","volume":"13","author":"WF Liu","year":"2012","unstructured":"Liu WF, Ji SR, Sun JJ, Zhang Y, Liu ZY, Liang AB, Zeng HZ (2012) CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer. Int J Mol Sci 13:6399\u20136406","journal-title":"Int J Mol Sci"},{"key":"11_CR84","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2559.2008.02971.x","volume":"52","author":"XY Zhong","year":"2008","unstructured":"Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ, Du H, Zhang GG, Hu Y, Lu AP, Li JY, Ji JF (2008) Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology 52:560\u2013568","journal-title":"Histopathology"},{"key":"11_CR85","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2011.02.004","volume":"304","author":"M Vougioukalaki","year":"2011","unstructured":"Vougioukalaki M, Kanellis DC, Gkouskou K, Eliopoulos AG (2011) Tpl2 kinase signal transduction in inflammation and cancer. Cancer Lett 304:80\u201389","journal-title":"Cancer Lett"},{"key":"11_CR86","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1242\/jcs.108.1.97","volume":"108","author":"R Ohara","year":"1995","unstructured":"Ohara R, Hirota S, Onoue H, Nomura S, Kitamura Y, Toyoshima K (1995) Identification of the cells expressing cot proto-oncogene mRNA. J Cell Sci 108:97\u2013103","journal-title":"J Cell Sci"},{"key":"11_CR87","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1093\/carcin\/bgt243","volume":"34","author":"HC Pan","year":"2013","unstructured":"Pan HC, Lai DW, Lan KH, Shen CC, Wu SM, Chiu CS, Wang KB, Sheu ML (2013) Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model. Carcinogenesis 34:2568\u20132579","journal-title":"Carcinogenesis"},{"key":"11_CR88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1742-4658.2008.06780.x","volume":"276","author":"YL Li","year":"2009","unstructured":"Li YL, Vergne J, Torchet C, Maurel MC (2009) In vitro selection of adenine-dependent ribozyme against Tpl2\/Cot oncogene. FEBS J 276:303\u2013314","journal-title":"FEBS J"},{"key":"11_CR89","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2337\/db10-0715","volume":"60","author":"JW Perfield 2nd","year":"2011","unstructured":"Perfield JW 2nd, Lee Y, Shulman GI, Samuel VT, Jurczak MJ, Chang E, Xie C, Tsichlis PN, Obin MS, Greenberg AS (2011) Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance. Diabetes 60:1168\u20131176","journal-title":"Diabetes"},{"key":"11_CR90","doi-asserted-by":"crossref","first-page":"e90793","DOI":"10.1371\/journal.pone.0090793","volume":"9","author":"L Yunlan","year":"2014","unstructured":"Yunlan L, Juan Z (2014) Qingshan L (2014) Antitumor activity of di-n-butyl-(2,6-difluorobenzohydrox-amato)tin (IV) against human gastric carcino-ma SGC-7901 cells via G2\/M cell cycle arrest and cell apoptosis. PLoS ONE 9:e90793","journal-title":"PLoS ONE"},{"key":"11_CR91","first-page":"7097","volume":"34","author":"CC Su","year":"2014","unstructured":"Su CC (2014) Tanshinone IIA inhibits gastric carcino-ma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression. Anticancer Res 34:7097\u20137110","journal-title":"Anticancer Res"},{"key":"11_CR92","first-page":"5454","volume":"8","author":"B Yan","year":"2015","unstructured":"Yan B, Peng ZY (2015) Honokiol induces cell cycle arrest and apoptosis in human gastric carcinoma MGC-803 cell line. Int J Clin Exp Med 8:5454\u20135461","journal-title":"Int J Clin Exp Med"},{"key":"11_CR93","first-page":"1208","volume":"58","author":"M Huang","year":"1998","unstructured":"Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM (1998) Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 58:1208\u20131216","journal-title":"Cancer Res"},{"key":"11_CR94","first-page":"3761","volume":"58","author":"T Hida","year":"1998","unstructured":"Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T (1998) Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58:3761\u20133764","journal-title":"Cancer Res"},{"key":"11_CR95","first-page":"4997","volume":"58","author":"H Wolff","year":"1998","unstructured":"Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristim\u00e4ki A (1998) Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58:4997\u20135001","journal-title":"Cancer Res"},{"key":"11_CR96","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0169-5002(00)00132-X","volume":"30","author":"Y Hosomi","year":"2000","unstructured":"Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, Nishiwaki Y, Ochiai A (2000) Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 30:73\u201381","journal-title":"Lung Cancer"},{"key":"11_CR97","doi-asserted-by":"crossref","first-page":"e60749","DOI":"10.1371\/journal.pone.0060749","volume":"8","author":"T Singh","year":"2013","unstructured":"Singh T, Katiyar SK (2013) Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE2-mediated activation of \u03b2-catenin signaling. PLoS ONE 8:e60749","journal-title":"PLoS ONE"},{"key":"11_CR98","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/0008-5472.CAN-07-5172","volume":"68","author":"JB Tuynman","year":"2008","unstructured":"Tuynman JB, Vermeulen L, Boon EM, Kemper K, Zwinderman AH, Peppelenbosch MP, Richel DJ (2008) Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. Cancer Res 68:1213\u20131220","journal-title":"Cancer Res"},{"key":"11_CR99","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/1535-7163.MCT-07-2063","volume":"7","author":"H Shlomo","year":"2008","unstructured":"Shlomo H, Simon JA (2008) A small-molecule inhibitor of Tcf\/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities. Mol Cancer Ther 7:521\u2013529","journal-title":"Mol Cancer Ther"},{"key":"11_CR100","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4161\/cbt.8.16.8961","volume":"8","author":"CE Wharry","year":"2009","unstructured":"Wharry CE, Haines KM, Carroll RG, May MJ (2009) Constitutive noncanonical NF-kappaB signaling in pancreatic cancer cells. Cancer Biol Ther 8:1567\u20131576","journal-title":"Cancer Biol Ther"},{"key":"11_CR101","doi-asserted-by":"crossref","first-page":"e21573","DOI":"10.1371\/journal.pone.0021573","volume":"6","author":"S Arora","year":"2011","unstructured":"Arora S, Bhardwaj A, Srivastava SK, Singh S, McClellan S, Wang B, Singh AP (2011) Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS ONE 6:e21573","journal-title":"PLoS ONE"},{"key":"11_CR102","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2174\/156652412803833508","volume":"12","author":"S Arora","year":"2012","unstructured":"Arora S, Singh S, Piazza GA, Contreras CM, Panyam J, Singh AP (2012) Honokiol: a novel natural agent for cancer prevention and therapy. Curr Mol Med 12:1244\u20131252","journal-title":"Curr Mol Med"}],"container-title":["Advances in Experimental Medicine and Biology","Anti-inflammatory Nutraceuticals and Chronic Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-41334-1_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T21:19:21Z","timestamp":1749590361000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-41334-1_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319413327","9783319413341"],"references-count":102,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-41334-1_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}